Cancer BiologybioRxivPreprint
CYP3A5 inhibition causes G1/S blockade and synergizes with CDK4/6 inhibitor to suppress prostate cancer cell growth: Implications in reducing health disparity
Jeetesh Sharma, Imran K. Mohammed, Richard L. Tillett…·Ranjana Mitra
This study shows that inhibiting CYP3A5 blocks the cell cycle and synergizes with CDK4/6 inhibitors to suppress prostate cancer growth, particularly in African-American patients.
DOI 10.1101/2024.10.01.616176